TRIM24 is known to be highly overexpressed in several cancers including non-small cell lung cancer [213], breast cancer [214], cervical cancer [215], hepatocellular carcinoma [216], as well as prostate [217] and gastric cancers [218]. This evidence concerns the gene TRIM24 and breast carcinoma.